Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Han BiomedicalROCO:6999 26 Gross Margin % is 78.42% as of Dec. 2025, which is 8% above its 10-year median of 72.76. GuruFocus rates ROCO:6999 with a GF Score™ of 26/100. The stock has 1 warning sign investors should review. Among 733 Biotechnology companies, Han Biomedical ranks better than 70.26% on this metric.
The historical rank and industry rank for Han Biomedical's Gross Margin % or its related term are showing as below:
ROCO:6999'
s Gross Margin % Range Over the Past 10 Years
Min: 62.22 Med: 72.76 Max: 78.13
Current: 78.13
During the past 5 years, the highestGross Margin % of Han Biomedical was 78.13%. The lowest was 62.22%. And the median was 72.76%.
ROCO:6999's Gross Margin % is ranked better than 70.26% of 733
companies
in the Biotechnology industry
Industry Median: 60.91
vs ROCO:6999: 78.13
Han Biomedical had a gross margin of 78.42% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Han Biomedical was 0.00% per year.
Han Biomedical (ROCO:6999) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Han Biomedical had a gross margin of 78.42% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Han Biomedical Gross Margin % Related Terms
Han Biomedical Gross Margin % Historical Data
* Premium members only.
The historical data trend for Han Biomedical's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6999 vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Han Biomedical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Han Biomedical Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Han Biomedical's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Han Biomedical's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Han Biomedical (ROCO:6999) has a Gross Margin % of 78.42% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Han Biomedical and its competitors. This is near median its historical median of 72.76. Over the past decade, Han Biomedical's Gross Margin % has ranged from 62.22 to 78.13. According to the industry distribution chart, Han Biomedical ranks #218 out of 733 companies in the Biotechnology industry, placing it in the top 29.7%.
Is Han Biomedical's Gross Margin % too high?
Han Biomedical's current Gross Margin % of 78.42% is near median its 10-year median of 72.76. Over the past 10 years, this metric has ranged from a low of 62.22 to a high of 78.13. The Biotechnology industry median Gross Margin % is 60.91. Han Biomedical's value of 78.42% is 28.7% above this industry median. Based on the distribution chart, Han Biomedical ranks #218 out of 733 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Han Biomedical has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Han Biomedical's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Han Biomedical ranks #218 out of 733 companies for Gross Margin %. This puts Han Biomedical in the upper half of its industry. The industry median Gross Margin % is 60.91. Han Biomedical's value of 78.42% is 28.7% above this benchmark. Historically, Han Biomedical's own Gross Margin % has ranged from 62.22 to 78.13 over the past decade. While the company's 10-year median is 72.76 vs. the industry median of 60.91, Han Biomedical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 733 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Han Biomedical's current Gross Margin % of 78.42% is 28.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Han Biomedical and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Han Biomedical's current Gross Margin % is 78.42%, which is near median its own 10-year median of 72.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Han Biomedical stock overvalued right now?
Han Biomedical (ROCO:6999) has a current Gross Margin % of 78.42%. The current Gross Margin % is 78.42%, which is near median its 10-year median of 72.76 and 28.7% above the Biotechnology industry median of 60.91. Han Biomedical's overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Han Biomedical (ROCO:6999), the current Gross Margin % is 78.42% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6999 has been successfully added to your 
